ReP USP - Resultado da busca

Artigo de periodico
Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII (2023)
Greco, Gabriel Luis Cardoso; Segretti, Natanael; Zapatero, Celerino Abad ; Movahedzadehc, Farahnaz; Hirata, Mario Hiroyuki ; Ferreira, Elizabeth Igne ; Ferreira, Glaucio Monteiro
Source: Journal of Biomolecular Structure and Dynamics. Unidade: FCF
Subjects: TUBERCULOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRECO, Gabriel Luis Cardoso et al. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics, 2023Tradução . . Disponível em: https://dx.doi.org/10.1080/07391102.2023.2270528. Acesso em: 05 nov. 2024.
APA
Greco, G. L. C., Segretti, N., Zapatero, C. A., Movahedzadehc, F., Hirata, M. H., Ferreira, E. I., & Ferreira, G. M. (2023). Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2023.2270528
NLM
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 nov. 05 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Vancouver
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 nov. 05 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Artigo de periodico
Drug/lead compound hydroxymethylation as a simple approach to enhance pharmacodynamic and pharmacokinetic properties (2022)
Santos, Soraya da Silva ; Gonzaga, Rodrigo Vieira ; Scarim, Cauê Benito ; Giarolla, Jeanine ; Primi, Marina Candido ; Chin, Chung Man ; Ferreira, Elizabeth Igne
Source: Frontiers in Chemistry. Unidade: FCF
Subjects: FARMACODINÂMICA, FARMACOCINÊTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Soraya da Silva et al. Drug/lead compound hydroxymethylation as a simple approach to enhance pharmacodynamic and pharmacokinetic properties. Frontiers in Chemistry, v. 9, p. 1-19 art. 734983, 2022Tradução . . Disponível em: https://doi.org/10.3389/fchem.2021.734983. Acesso em: 05 nov. 2024.
APA
Santos, S. da S., Gonzaga, R. V., Scarim, C. B., Giarolla, J., Primi, M. C., Chin, C. M., & Ferreira, E. I. (2022). Drug/lead compound hydroxymethylation as a simple approach to enhance pharmacodynamic and pharmacokinetic properties. Frontiers in Chemistry, 9, 1-19 art. 734983. doi:10.3389/fchem.2021.734983
NLM
Santos S da S, Gonzaga RV, Scarim CB, Giarolla J, Primi MC, Chin CM, Ferreira EI. Drug/lead compound hydroxymethylation as a simple approach to enhance pharmacodynamic and pharmacokinetic properties [Internet]. Frontiers in Chemistry. 2022 ; 9 1-19 art. 734983.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fchem.2021.734983
Vancouver
Santos S da S, Gonzaga RV, Scarim CB, Giarolla J, Primi MC, Chin CM, Ferreira EI. Drug/lead compound hydroxymethylation as a simple approach to enhance pharmacodynamic and pharmacokinetic properties [Internet]. Frontiers in Chemistry. 2022 ; 9 1-19 art. 734983.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fchem.2021.734983
Artigo de periodico
Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis (2021)
Primi, Marina Candido ; Tavares, Maurício Temotheo ; Klein, Larry L; Izard, Tina; Sant'Anna, Carlos M. R; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Current Topics in Medicinal Chemistry. Unidade: FCF
Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 05 nov. 2024.
APA
Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
NLM
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Vancouver
Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/1568026621666210728094804
Trabalho de evento-resumo periodico
Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation (2017)
Primi, Marina Candido; Klein, Larry; Sant’Anna, Carlos Mauricio Rabello de; Franzblau, Scott Gary; Ferreira, Elizabeth Igne
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, TUBERCULOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIMI, Marina Candido et al. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 2017
APA
Primi, M. C., Klein, L., Sant’Anna, C. M. R. de, Franzblau, S. G., & Ferreira, E. I. (2017). Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Primi MC, Klein L, Sant’Anna CMR de, Franzblau SG, Ferreira EI. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 26 res. FCF047.[citado 2024 nov. 05 ]
Vancouver
Primi MC, Klein L, Sant’Anna CMR de, Franzblau SG, Ferreira EI. Phosphopantetheine adenylyltransferase potential inhibitors for the treatment of tuberculosis: design, synthesis and biological activity evaluation. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 26 res. FCF047.[citado 2024 nov. 05 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Non normalized affiliation